865 related articles for article (PubMed ID: 26941360)
1. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
Lala-Tabbert N; Fu D; Wiper-Bergeron N
Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of Dystrophin Expressing Chimeric Human Cells of Myoblast/Mesenchymal Stem Cell Origin Improves Function in Duchenne Muscular Dystrophy Model.
Siemionow M; Szilagyi E; Cwykiel J; Domaszewska-Szostek A; Heydemann A; Garcia-Martinez J; Siemionow K
Stem Cells Dev; 2021 Feb; 30(4):190-202. PubMed ID: 33349121
[TBL] [Abstract][Full Text] [Related]
3. Losartan enhances the success of myoblast transplantation.
Fakhfakh R; Lamarre Y; Skuk D; Tremblay JP
Cell Transplant; 2012; 21(1):139-52. PubMed ID: 21535912
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx mice.
Hindi SM; Shin J; Ogura Y; Li H; Kumar A
PLoS One; 2013; 8(8):e72121. PubMed ID: 23977226
[TBL] [Abstract][Full Text] [Related]
5. CCAAT/enhancer binding protein β is required for satellite cell self-renewal.
Lala-Tabbert N; AlSudais H; Marchildon F; Fu D; Wiper-Bergeron N
Skelet Muscle; 2016 Dec; 6(1):40. PubMed ID: 27923399
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of follistatin in human myoblasts increases their proliferation and differentiation, and improves the graft success in SCID mice.
Benabdallah BF; Bouchentouf M; Rousseau J; Tremblay JP
Cell Transplant; 2009; 18(7):709-18. PubMed ID: 19520047
[TBL] [Abstract][Full Text] [Related]
7. Effects of omega-3 on matrix metalloproteinase-9, myoblast transplantation and satellite cell activation in dystrophin-deficient muscle fibers.
de Carvalho SC; Hindi SM; Kumar A; Marques MJ
Cell Tissue Res; 2017 Sep; 369(3):591-602. PubMed ID: 28623422
[TBL] [Abstract][Full Text] [Related]
8. PITX2 Enhances the Regenerative Potential of Dystrophic Skeletal Muscle Stem Cells.
Vallejo D; Hernández-Torres F; Lozano-Velasco E; Rodriguez-Outeiriño L; Carvajal A; Creus C; Franco D; Aránega AE
Stem Cell Reports; 2018 Apr; 10(4):1398-1411. PubMed ID: 29641992
[TBL] [Abstract][Full Text] [Related]
9. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy.
He R; Li H; Wang L; Li Y; Zhang Y; Chen M; Zhu Y; Zhang C
Biol Res; 2020 May; 53(1):22. PubMed ID: 32430065
[TBL] [Abstract][Full Text] [Related]
10. Long-term engraftment of myogenic progenitors from adipose-derived stem cells and muscle regeneration in dystrophic mice.
Zhang Y; Zhu Y; Li Y; Cao J; Zhang H; Chen M; Wang L; Zhang C
Hum Mol Genet; 2015 Nov; 24(21):6029-40. PubMed ID: 26264578
[TBL] [Abstract][Full Text] [Related]
11. CCAAT/enhancer binding protein beta protects muscle satellite cells from apoptosis after injury and in cancer cachexia.
Marchildon F; Fu D; Lala-Tabbert N; Wiper-Bergeron N
Cell Death Dis; 2016 Feb; 7(2):e2109. PubMed ID: 26913600
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo gene editing of the dystrophin gene in muscle stem cells mediated by peptide nucleic acid single stranded oligodeoxynucleotides induces stable expression of dystrophin in a mouse model for Duchenne muscular dystrophy.
Nik-Ahd F; Bertoni C
Stem Cells; 2014 Jul; 32(7):1817-30. PubMed ID: 24753122
[TBL] [Abstract][Full Text] [Related]
13. Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice.
Fakhfakh R; Michaud A; Tremblay JP
Mol Ther; 2011 Jan; 19(1):204-10. PubMed ID: 20700111
[TBL] [Abstract][Full Text] [Related]
14. [Co-transplantation of myoblasts and schwann cells in the therapy of Duchenne muscular dystrophy].
Luo L; Zhou HY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):101-5. PubMed ID: 21355312
[TBL] [Abstract][Full Text] [Related]
15. Sunitinib promotes myogenic regeneration and mitigates disease progression in the mdx mouse model of Duchenne muscular dystrophy.
Fontelonga TM; Jordan B; Nunes AM; Barraza-Flores P; Bolden N; Wuebbles RD; Griner LM; Hu X; Ferrer M; Marugan J; Southall N; Burkin DJ
Hum Mol Genet; 2019 Jul; 28(13):2120-2132. PubMed ID: 30806670
[TBL] [Abstract][Full Text] [Related]
16. Fibrin gel improves the survival of transplanted myoblasts.
Gerard C; Forest MA; Beauregard G; Skuk D; Tremblay JP
Cell Transplant; 2012; 21(1):127-37. PubMed ID: 21535909
[TBL] [Abstract][Full Text] [Related]
17. Autologous Cell Therapy Approach for Duchenne Muscular Dystrophy using PiggyBac Transposons and Mesoangioblasts.
Iyer PS; Mavoungou LO; Ronzoni F; Zemla J; Schmid-Siegert E; Antonini S; Neff LA; Dorchies OM; Jaconi M; Lekka M; Messina G; Mermod N
Mol Ther; 2018 Apr; 26(4):1093-1108. PubMed ID: 29503200
[TBL] [Abstract][Full Text] [Related]
18. Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy.
Siemionow M; Cwykiel J; Heydemann A; Garcia-Martinez J; Siemionow K; Szilagyi E
Stem Cell Rev Rep; 2018 Apr; 14(2):189-199. PubMed ID: 29305755
[TBL] [Abstract][Full Text] [Related]
19. Mdm2 promotes myogenesis through the ubiquitination and degradation of CCAAT/enhancer-binding protein β.
Fu D; Lala-Tabbert N; Lee H; Wiper-Bergeron N
J Biol Chem; 2015 Apr; 290(16):10200-7. PubMed ID: 25720496
[TBL] [Abstract][Full Text] [Related]
20. Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy.
Qu Z; Huard J
Gene Ther; 2000 Mar; 7(5):428-37. PubMed ID: 10694825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
